NewsNow: Stem Cells news | Breaking News & Search 24/7
Read the latest Stem Cells headlines, on NewsNow: the one-stop shop for Stem Cells news
Source: newsnow.co.uk
Begin Clinical Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Begin Clinical Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Begin Clinical Study Today - Breaking & Trending Today
Financial News Media | Moleculin Announces FDA Permission to Begin Clinical Study of Annamycin for Sarcoma Lung Metastases
Houston, TX – December 17, 2020 – Moleculin Biotech, Inc., (NASDAQ: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that the US Food and Drug Administration (FDA) is allowing the company’s Investigational New Drug (IND) application to study Annamycin for the treatment of soft tissue sarcoma lung metastases to go into effect. This allows Moleculin to begin a Phase 1B/2 clinical trial in the US for patients with soft tissue sarcoma that has metastasized t...
Source: financialnewsmedia.com
Global Sarcoma Drugs Market Size Could Reach $1.2 Billion By 2023
Global Sarcoma Drugs Market Size Could Reach $1.2 Billion By 2023 Financialnewsmedia.com News Commentary PALM BEACH, Fla., Dec. 17, 2020 /PRNewswire/ -- Soft tissue sarcoma (STS) is a rare type of cancer that develops in tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. Generally occurring in the muscles, tissues, and blood vessels that protect, support and surround the organs. Moreover, it is not categorized as tumor, but can be life-threatening if the cancer spreads to other parts of the body. Currently, there are very few products approved for the treatment of sof...
Source: finanznachrichten.de